Novartis Ag (NVS) FCF Margin (2009 - 2026)
Novartis Ag (NVS) posted FCF Margin of 43.05% for Q2 2026, down 6.72 percentage points from 49.77% a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) FCF Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Novartis Ag was 38.20%, down 5.47 percentage points year-over-year; for FY2025, it came in at 37.94%, up 0.21 percentage points from FY2024.
- Annual FCF Margin shows a five-year change of +12.51 percentage points (FY2020 to FY2025).
- In prior years, Novartis Ag's FCF Margin was 37.73% in FY2024 (-0.08 pp), 37.81% in FY2023 (+6.09 pp), 31.73% in FY2022 (+3.83 pp) and 27.90% in FY2021 (+2.47 pp).
- The Q2 2026 figure stands as the lowest quarterly FCF Margin since Q2 2024.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q1 2023, with a gain of 22.78 percentage points; the weakest was Q2 2026, with a drop of 6.72 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 30.39% |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 23.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.05% |
| Jun 30, 2025 | 49.77% |
| Jun 30, 2024 | 41.04% |
| Jun 30, 2023 | 32.72% |
| Mar 31, 2023 | 37.99% |
| Dec 31, 2022 | 32.10% |
| Sep 30, 2022 | 35.84% |
| Jun 30, 2022 | 31.39% |
| Mar 31, 2022 | 15.21% |
| Dec 31, 2021 | 32.84% |
| Sep 30, 2021 | 40.49% |
| Jun 30, 2021 | 34.59% |
| Mar 31, 2021 | 19.14% |
| Dec 31, 2020 | 21.46% |
| Sep 30, 2020 | 28.02% |
| Jun 30, 2020 | 37.01% |
| Mar 31, 2020 | 22.51% |
| Jun 30, 2019 | 32.05% |
| Dec 31, 2018 | 29.24% |
| Sep 30, 2018 | 31.42% |
API Access
Novartis Ag FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();